5-147828151-T-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001379610.1(SPINK1):​c.88-23A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00273 in 1,561,578 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.0021 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 8 hom. )

Consequence

SPINK1
NM_001379610.1 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.915
Variant links:
Genes affected
SPINK1 (HGNC:11244): (serine peptidase inhibitor Kazal type 1) The protein encoded by this gene is a trypsin inhibitor, which is secreted from pancreatic acinar cells into pancreatic juice. It is thought to function in the prevention of trypsin-catalyzed premature activation of zymogens within the pancreas and the pancreatic duct. Mutations in this gene are associated with hereditary pancreatitis and tropical calcific pancreatitis. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 0 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 5-147828151-T-A is Benign according to our data. Variant chr5-147828151-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 239508.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-147828151-T-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00208 (316/152280) while in subpopulation NFE AF = 0.00378 (257/68006). AF 95% confidence interval is 0.0034. There are 0 homozygotes in GnomAd4. There are 140 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 316 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPINK1NM_001379610.1 linkc.88-23A>T intron_variant Intron 2 of 3 ENST00000296695.10 NP_001366539.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPINK1ENST00000296695.10 linkc.88-23A>T intron_variant Intron 2 of 3 1 NM_001379610.1 ENSP00000296695.5 P00995
SPINK1ENST00000510027.2 linkc.88-23A>T intron_variant Intron 2 of 2 3 ENSP00000427376.1 D6RIU5
SPINK1ENST00000505722.1 linkn.-21A>T upstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.00208
AC:
316
AN:
152162
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00378
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00246
AC:
590
AN:
239486
AF XY:
0.00256
show subpopulations
Gnomad AFR exome
AF:
0.000319
Gnomad AMR exome
AF:
0.00106
Gnomad ASJ exome
AF:
0.00296
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000935
Gnomad NFE exome
AF:
0.00451
Gnomad OTH exome
AF:
0.00270
GnomAD4 exome
AF:
0.00280
AC:
3945
AN:
1409298
Hom.:
8
Cov.:
22
AF XY:
0.00280
AC XY:
1970
AN XY:
703776
show subpopulations
Gnomad4 AFR exome
AF:
0.000432
AC:
14
AN:
32390
Gnomad4 AMR exome
AF:
0.00104
AC:
46
AN:
44326
Gnomad4 ASJ exome
AF:
0.00249
AC:
64
AN:
25712
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39154
Gnomad4 SAS exome
AF:
0.0000592
AC:
5
AN:
84466
Gnomad4 FIN exome
AF:
0.00135
AC:
70
AN:
51886
Gnomad4 NFE exome
AF:
0.00339
AC:
3619
AN:
1067126
Gnomad4 Remaining exome
AF:
0.00207
AC:
121
AN:
58568
Heterozygous variant carriers
0
191
381
572
762
953
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
112
224
336
448
560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00208
AC:
316
AN:
152280
Hom.:
0
Cov.:
32
AF XY:
0.00188
AC XY:
140
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.000337
AC:
0.000336895
AN:
0.000336895
Gnomad4 AMR
AF:
0.00163
AC:
0.00163463
AN:
0.00163463
Gnomad4 ASJ
AF:
0.00173
AC:
0.00172911
AN:
0.00172911
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.000207
AC:
0.000207211
AN:
0.000207211
Gnomad4 FIN
AF:
0.000942
AC:
0.00094162
AN:
0.00094162
Gnomad4 NFE
AF:
0.00378
AC:
0.00377908
AN:
0.00377908
Gnomad4 OTH
AF:
0.00142
AC:
0.00141777
AN:
0.00141777
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00237
Hom.:
0
Bravo
AF:
0.00202

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary pancreatitis Benign:4
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 26, 2020
Sema4, Sema4
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Mar 31, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:3
May 22, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 24, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary pancreatitis;C1842402:Tropical pancreatitis Benign:1
May 23, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
12
DANN
Benign
0.64
La Branchor
0.60
BranchPoint Hunter
0.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199929811; hg19: chr5-147207714; API